Related Experiment Video
Updated: Jul 13, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Inactive Matrix Gla Protein in Relation to Renal and Cardiac Functions and Cardiac Valvular Calcification Among Type
Sara Reda1, Olfat Fawzy1, Doaa Sayed1
1Department of Endocrinology and Metabolism, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Background:
Matrix Gla protein (MGP) is a robust innate suppressor of the detrimental process of vascular calcification in the human body.
Objectives:
The interrelationship between circulating MGP levels and renal and cardiac dysfunction, besides echocardiographic calcification score (ECS) was investigated in a sample of type 2 diabetes (T2D) patients.
Methods:
The study included 130 subjects. They were 95 patients with T2D and 35 age- and sex-matched healthy controls. Patients were further subdivided into 52 T2D patients without DKD (eGFR ⩾ 60 ml/minute/1.73 m²) and 43 T2D persons with DKD (eGFR > 60 ml/minute/1.73 m²). Serum MGP levels, determined by ELISA, renal function tests, lipid profile, and echocardiography were studied in all participants.
Results:
Significantly elevated circulating inactive MGP level was noted in individuals having T2D compared to controls. It correlated negatively with eGFR and left ventricular (LV) diastolic and systolic functions and positively with indices of LV hypertrophy. ECS was significantly increased in both T2D groups compared to controls and in DKD group compared to the diabetic group without DKD. A significant positive correlation was observed between inactive MGP and ECS.
Conclusion:
Serum inactive MGP may contribute to the development of DKD and to the associated process of cardiac valvular calcification. It may be a beneficial diagnostic marker for early prediction of cardiac calcification and preclinical LV systolic and diastolic dysfunction in T2D patients, especially in those complicated with DKD.
Insights
Elevated inactive Matrix Gla protein (MGP) in type 2 diabetes (T2D) patients correlates with kidney disease and cardiac calcification. This suggests MGP may predict cardiovascular complications in T2D.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Endocrinology
Background:
- Matrix Gla protein (MGP) is a key inhibitor of vascular calcification.
- Vascular calcification is a common complication in type 2 diabetes (T2D).
Purpose of the Study:
- To investigate the relationship between circulating MGP levels and renal dysfunction, cardiac dysfunction, and echocardiographic calcification score (ECS) in T2D patients.
- To assess MGP as a potential biomarker for cardiovascular complications in T2D.
Main Methods:
- Study included 130 participants: 95 T2D patients (with and without diabetic kidney disease - DKD) and 35 healthy controls.
- Serum MGP levels were measured using ELISA.
- Renal function (eGFR), cardiac function (echocardiography), and lipid profiles were assessed.
Main Results:
- T2D patients had significantly higher inactive MGP levels than controls.
- Inactive MGP levels negatively correlated with eGFR and left ventricular (LV) function, and positively with LV hypertrophy.
- ECS was higher in T2D patients, particularly those with DKD, and positively correlated with inactive MGP.
Conclusions:
- Serum inactive MGP may contribute to diabetic kidney disease (DKD) and cardiac valvular calcification in T2D.
- Inactive MGP shows potential as a diagnostic marker for early prediction of cardiac calcification and LV dysfunction in T2D, especially with DKD.
More Related Videos
08:55Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification
Published on: November 20, 2017
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Chronic Kidney Disease II: Clinical Manifestations
Proteoglycans
Insulin Secretory Vesicles
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...